US Patent Issued to University of Cincinnati, Children's Hospital Medical Center, Christian-Albrechts-Universitat Zu Kiel on July 21 for "Suppressing IgE-mediated allergy by desensitization with monovalent anti-FCeRIa monoclonal antibody" (American, Israeli, German Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,719, issued on July 21, was assigned to University of Cincinnati (Cincinnati), Children's Hospital Medical Center (Cincinnati) and Christian-Albrechts-Universitat Zu Kiel (Kiel, Germany).

"Suppressing IgE-mediated allergy by desensitization with monovalent anti-FCeRIa monoclonal antibody" was invented by Fred Finkelman (Netanya, Israel), Suzanne Morris (Mason, Ohio), Marat Khodoun (Mason, Ohio), Crystal Potter (Fairfield, Ohio), Elizabeth Angerman (Fort Thomas, Ky.), Andrew Herr (Cincinnati) and Matthias Peipp (Hamburg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "A monovalent monoclonal antibody is provided, the antibody including one lig...